Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Эффективность эторикоксиба в редукции хронической боли в области спины
Эффективность эторикоксиба в редукции хронической боли в области спины
О.В.Воробьева. Эффективность эторикоксиба в редукции хронической боли в области спины. Consilium Medicum. Неврология (Прил.). 2011; 2: 41-45.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Breivik H et al. Surwey of chronic pain in Europe prevalence, impact on daily life and treatment. Eur J Pain 2006; 10 (4): 287–333.
2. DePalma MJ, Ketchum JM, Saullo T. What is the source of chronic low back pain and does age play a role? Pain Med 2011; 12 (2): 224–33.
3. Lundberg U. Psychophysiology of Work: Stress, Gender, Endocrine Response, and Work-Related Upper Extremity Disorders. Am J Ind Med 2002; 41: 383–92.
4. Воробьева О.В., Вауличева А.Л. Хронизация боли в спине у мужчин трудоспособного возраста. Врач. 2010; 9: 47–50.
5. Khruakhorn S, Sritipsukho P, Siripakarn Y, Vachalathiti R. Prevalence and risk factors of low back pain among the university staff. J Med Assoc Thai 2010; 93 (Suppl. 7): S142–8.
6. Katz JN et al. Seven- to 10-year outcome of decompressive surgery for degenerative lumbar spinal stenosis. Spine 1996; 21: 92–8.
7. Rives PA, Douglass AB. Evaluation and treatment of low back pain in family practice. J Am Board Fam Pract 2004; 17: S23–31.
8. Clarke R, Derry S, Moore R, McQuay H J. Single dose oral etoricoxib for acute postoperative pain in adults. Cochrane Database syst rew 2009; 15 (2).
9. Pallay RM et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol 2004; 33 (4): 257–66.
10. Birbara CA et al. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability – a randomized, placebo controlled, 3-month trial. J Pain 2003; 4 (3): 307–15.
11. Zerbini C et al. Efficacy of etoricoxib 60mg/day abd diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain; results of a 4 week, multinational, randomized, double-blind study. Curr Med Res Opin 2005; 21 (12): 2037–49.
2. DePalma MJ, Ketchum JM, Saullo T. What is the source of chronic low back pain and does age play a role? Pain Med 2011; 12 (2): 224–33.
3. Lundberg U. Psychophysiology of Work: Stress, Gender, Endocrine Response, and Work-Related Upper Extremity Disorders. Am J Ind Med 2002; 41: 383–92.
4. Воробьева О.В., Вауличева А.Л. Хронизация боли в спине у мужчин трудоспособного возраста. Врач. 2010; 9: 47–50.
5. Khruakhorn S, Sritipsukho P, Siripakarn Y, Vachalathiti R. Prevalence and risk factors of low back pain among the university staff. J Med Assoc Thai 2010; 93 (Suppl. 7): S142–8.
6. Katz JN et al. Seven- to 10-year outcome of decompressive surgery for degenerative lumbar spinal stenosis. Spine 1996; 21: 92–8.
7. Rives PA, Douglass AB. Evaluation and treatment of low back pain in family practice. J Am Board Fam Pract 2004; 17: S23–31.
8. Clarke R, Derry S, Moore R, McQuay H J. Single dose oral etoricoxib for acute postoperative pain in adults. Cochrane Database syst rew 2009; 15 (2).
9. Pallay RM et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol 2004; 33 (4): 257–66.
10. Birbara CA et al. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability – a randomized, placebo controlled, 3-month trial. J Pain 2003; 4 (3): 307–15.
11. Zerbini C et al. Efficacy of etoricoxib 60mg/day abd diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain; results of a 4 week, multinational, randomized, double-blind study. Curr Med Res Opin 2005; 21 (12): 2037–49.
Авторы
О.В.Воробьева
Кафедра нервных болезней ФППОВ ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздравсоцразвития РФ
Кафедра нервных болезней ФППОВ ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздравсоцразвития РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.